If the last two years were defined by the breathless hype of experimentation, 2026 marks the healthcare industry’s decisive transition from "flashy, one-off experiments" to "top-down programs designed for measurable impact". Across the digital health landscape, executives agree that the "pilot era is ending," with the focus shifting entirely to systems that can be "governed, audited, and trusted" at scale.
The narrative for the coming year is no longer about the novelty of generative AI
Read More
PwC 2026 Outlook: Health Services M&A Poised for Rebound as AI Becomes “Core Driver” of Value
What You Should Know:
- According to PwC's 2026 Health Services Deals Outlook, the M&A market is set to regain momentum in both deal value and volume after a cooling period in 2025.
- The report highlights a strategic pivot among private equity investors away from reimbursement-heavy assets toward AI-enabled software and services that drive margin expansion without adding labor. With the IPO window reopening and "mega-funds" returning to offense, the winners in 2026 will be
Read More
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
- MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on "deep health" solutions that address diseases linked to environmental toxins and synthetic exposures.
- Backed by institutional heavyweights like Industry Ventures and the State of New York, the firm plans to deploy checks ranging from $1 million to $4 million into startups that move beyond symptom management
Read More
Tampa General Hospital Partners with Reimagine Care to Launch AI-Enabled Virtual Oncology Support
What You Should Know:
- Tampa General Hospital (TGH) Cancer Institute has partnered with Reimagine Care to integrate an AI-enabled virtual cancer care program into its clinical pathways.
- The collaboration, backed by an investment from TGH Ventures, provides 24/7 symptom monitoring and triage to reduce emergency department visits and administrative burden on oncologists. This move aims to expand capacity and improve patient outcomes across Florida, a state facing 115,000 new
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Philips Acquires SpectraWAVE to “Double Down” on AI-Powered Coronary Imaging
What You Should Know:
- Philips has agreed to acquire SpectraWAVE, Inc., a move designed to bolster its leadership in image-guided therapy by integrating SpectraWAVE’s AI-powered coronary imaging and physiology assessments into the Philips Azurion platform.
- The acquisition adds critical next-generation capabilities, including DeepOCT (optical coherence tomography) and wire-free Fractional Flow Reserve (FFR), to Philips' existing portfolio.
- The strategic expansion aims to
Read More
Auxira Health Raises $7.8M to Solve the Cardiology Shortage with Virtual Clinical Pods
What You Should Know:
- Auxira Health, a virtual cardiology company co-developed by MedStar Health, has secured $7.8M in seed funding to address the growing cardiologist shortage and clinician burnout crisis.
- Unlike standard telehealth platforms, Auxira embeds dedicated "clinical pods" of nurses and advanced practitioners directly into existing practice workflows, training them on-site to ensure seamless integration.
- The funding will fuel the company's expansion,
Read More
Mount Sinai’s AI Tool “V2P” Predicts Disease Type from Genetic Mutations
What You Should Know:
- Scientists at the Icahn School of Medicine at Mount Sinai have developed a new artificial intelligence tool called V2P (Variant to Phenotype) that identifies not only disease-causing genetic mutations but also predicts the specific diseases they may trigger.
- Published in Nature Communications, this machine learning model improves diagnostic speed and accuracy by linking genetic variants to phenotypic outcomes, moving beyond simple "harmful vs. benign"
Read More
M&A: Sentact Acquires Performance Health Partners and Vizient PSO to Create Patient Safety Powerhouse
What You Should Know:
- Sentact has executed a major strategic expansion by acquiring two significant players in the patient safety space: Performance Health Partners (PHP), the #1 Best-in-KLAS provider of safety incident management software, and the Vizient Patient Safety Organization (PSO), one of the nation's largest PSOs.
- The double acquisition positions Sentact to offer a comprehensive, end-to-end safety platform that combines top-tier incident reporting technology with
Read More
Deloitte 2026 Outlook: Why Traditional Health Strategies Will Fail in the Face of Regulatory Uncertainty
What You Should Know:
- Deloitte’s 2026 US Health Care Outlook reveals a dangerous disconnect: while nearly 70% of health executives expect to outperform competitors next year, the "traditional playbook" of market expansion and cost-cutting is no longer sufficient.
- Amid rising regulatory uncertainty and financial pressure, the report identifies three mandatory pivots for survival: empowering consumer health with digital experiences, scaling generative and agentic AI across
Read More
